4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-24-029603
SVP, Head of Finance & Admin. sold 2,273 shares at $25.85 ($58,757)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Scalzo Richard William · SVP, Head of Finance & Admin.
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-03-07 | Sale : show line 1 in the form 10b5-1 | −2,273 | $25.85 | $58,757 | 121,955 | D |
| Open-market sales · 2,273 sh · avg $25.85 · $58,757 | ||||||
Loading xslF345X05/ownership.xml…